bifunctional lentivirus-based gene therapy (Genethon/INSERM/University of Modena and Reggio Emilia/Assistance Publique-Hopitaux de Paris)
N/A
Report date: 2025/01/26 19:23:31
Base Information
Drug Namebifunctional lentivirus-based gene therapy (Genethon/INSERM/University of Modena and Reggio Emilia/Assistance Publique-Hopitaux de Paris)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGenethon
China Registration ClassN/A
Develop Information
Active CompaniesInstitut National De La Sante Et De La Recherche MedicaleGenethonAssistance Publique Hopitaux De Paris +[4]
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A